news The role of ‘extra’ DNA in cancer evolution and therapy resistance 26 April 2018 | By Drug Target Review A team of scientists have reported that tumour progression was often driven by cancer-promoting genes, known as oncogenes, on extrachromosomal pieces of DNA.